Financials

  • Market Capitalization 231.1 M
  • Employee 106
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.81
Fiyat/satışlar oranı
262.27

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3509
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.59 USD+1.41%-4.27%+1.70%-54.44%239.21 M USD
3518
IVVD
Invivyd, Inc. - Common Stock
0.80 USD+1.27%-15.79%-9.09%+14.29%235.69 M USD
3539
TARA
Protara Therapeutics, Inc. - Common Stock
4.09 USD-2.15%-3.31%+3.54%+32.79%229.88 M USD
3550
KPTI
Karyopharm Therapeutics Inc. - Common Stock
10.01 USD-0.40%-0.10%+3.84%+3.84%226.86 M USD